Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,776 | 434 | 97.0% |
| Education | $177.79 | 13 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $921.49 | 81 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $820.73 | 36 | $0 (2021) |
| Novo Nordisk Inc | $513.16 | 55 | $0 (2021) |
| Amgen Inc. | $471.51 | 32 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $367.93 | 32 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $312.17 | 26 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $288.44 | 14 | $0 (2021) |
| Astellas Pharma US Inc | $252.66 | 10 | $0 (2020) |
| Amarin Pharma Inc. | $252.37 | 21 | $0 (2021) |
| GlaxoSmithKline, LLC. | $247.90 | 21 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $310.52 | 21 | Novo Nordisk Inc ($50.94) |
| 2020 | $662.50 | 46 | Amarin Pharma Inc. ($182.75) |
| 2019 | $1,066 | 80 | PFIZER INC. ($225.11) |
| 2018 | $1,163 | 85 | AstraZeneca Pharmaceuticals LP ($274.85) |
| 2017 | $2,752 | 215 | PFIZER INC. ($451.12) |
All Payment Transactions
447 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Gastroenterology | ||||||
| 07/09/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $16.52 | General |
| 06/14/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Diabetes | ||||||
| 05/20/2021 | Roche Diagnostics Corporation | CINtec PLUS Cytology (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Tissue Diagnostics | ||||||
| 05/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 05/15/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $11.96 | General |
| 05/05/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: DIABETES | ||||||
| 04/28/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Bone Health | ||||||
| 04/23/2021 | UPSHER-SMITH LABORATORIES LLC | TOSYMRA (Drug), ZEMBRACE SYMTOUCH | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROLOGY | ||||||
| 04/19/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Cardiovascular | ||||||
| 02/25/2021 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Cardiovascular | ||||||
| 01/29/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular | ||||||
| 01/27/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Respiratory | ||||||
| 01/21/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/15/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular | ||||||
| 01/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Diabetes | ||||||
| 01/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/18/2020 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Inflammation | ||||||
| 12/14/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Cardiovascular | ||||||
| 12/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 8 | 349 | 367 | $55,309 | $20,919 |
| 2020 | 17 | 930 | 1,295 | $133,884 | $58,038 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 83 | 83 | $13,695 | $10,973 | 80.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 105 | $17,640 | $4,523 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 66 | $7,392 | $1,791 | 24.2% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 31 | 31 | $9,982 | $1,171 | 11.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $2,736 | $1,017 | 37.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 41 | 41 | $1,271 | $758.91 | 59.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 11 | 13 | $1,729 | $463.43 | 26.8% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 13 | 16 | $864.00 | $222.56 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 161 | 161 | $26,565 | $18,632 | 70.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 155 | 202 | $33,936 | $8,745 | 25.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 126 | 168 | $18,816 | $4,500 | 23.9% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 19 | 19 | $4,370 | $4,232 | 96.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 85 | 85 | $3,995 | $3,987 | 99.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 23 | 23 | $5,750 | $3,916 | 68.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 27 | 27 | $3,132 | $3,075 | 98.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 16 | 16 | $4,528 | $2,377 | 52.5% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 35 | 47 | $6,251 | $1,932 | 30.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 92 | 93 | $4,278 | $1,539 | 36.0% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 38 | 38 | $12,236 | $1,483 | 12.1% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 27 | 162 | $3,564 | $1,272 | 35.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 47 | 47 | $2,162 | $772.33 | 35.7% |
| 85610 | Blood test, clotting time | Office | 2020 | 24 | 149 | $1,639 | $634.35 | 38.7% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 26 | 28 | $1,494 | $485.94 | 32.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 16 | 16 | $496.00 | $291.68 | 58.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 14 | $672.00 | $162.87 | 24.2% |
About Dr. John Stanley, MD
Dr. John Stanley, MD is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457358459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Stanley, MD has received a total of $5,954 in payments from pharmaceutical and medical device companies, with $310.52 received in 2021. These payments were reported across 447 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,776).
As a Medicare-enrolled provider, Stanley has provided services to 1,279 Medicare beneficiaries, totaling 1,662 services with total Medicare billing of $78,957. Data is available for 2 years (2020–2021), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Kansas City, MO
- Active Since 07/05/2005
- Last Updated 09/26/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1457358459
Products in Payments
- FARXIGA (Drug) $422.99
- CHANTIX (Drug) $422.63
- SYMBICORT (Drug) $296.48
- XARELTO (Drug) $293.07
- ENTRESTO (Drug) $288.44
- Vascepa (Drug) $252.37
- Victoza (Drug) $248.67
- Prolia (Biological) $227.47
- ELIQUIS (Drug) $172.05
- LYRICA (Drug) $147.80
- VIAGRA (Drug) $132.59
- Ozempic (Drug) $124.75
- TOUJEO (Drug) $119.87
- JANUVIA (Drug) $113.25
- Livalo (Drug) $106.29
- TRADJENTA (Drug) $104.89
- Tresiba (Drug) $102.85
- EVENITY (Biological) $96.17
- BREO (Drug) $96.01
- TRULICITY (Drug) $94.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Eric Aspinwall, Md, MD
Family Medicine — Payments: $33,048
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Dr. Blair Thedinger
Family Medicine — Payments: $19,784
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Teresa Marshall, M.d, M.D
Family Medicine — Payments: $19,051